FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3121304865> ?p ?o ?g. }

• W3121304865 endingPage "361" @default.
• W3121304865 startingPage "295" @default.
• W3121304865 abstract "The 14 th edition of the Workshop on Recent Issues in Bioanalysis (14 th WRIB) was held virtually on June 15-29, 2020 with an attendance of over 1000 representatives from pharmaceutical/biopharmaceutical companies, biotechnology companies, contract research organizations, and regulatory agencies worldwide. The 14 th WRIB included three Main Workshops, seven Specialized Workshops that together spanned 11 days in order to allow exhaustive and thorough coverage of all major issues in bioanalysis, biomarkers, immunogenicity, gene therapy and vaccine. Moreover, a comprehensive vaccine assays track; an enhanced cytometry track and updated Industry/Regulators consensus on BMV of biotherapeutics by LCMS were special features in 2020. As in previous years, this year's WRIB continued to gather a wide diversity of international industry opinion leaders and regulatory authority experts working on both small and large molecules to facilitate sharing and discussions focused on improving quality, increasing regulatory compliance and achieving scientific excellence on bioanalytical issues. This 2020 White Paper encompasses recommendations emerging from the extensive discussions held during the workshop, and is aimed to provide the Global Bioanalytical Community with key information and practical solutions on topics and issues addressed, in an effort to enable advances in scientific excellence, improved quality and better regulatory compliance. Due to its length, the 2020 edition of this comprehensive White Paper has been divided into three parts for editorial reasons. This publication covers the recommendations on (Part 2A) BAV, PK LBA, Flow Cytometry Validation and Cytometry Innovation and (Part 2B) Regulatory Input. Part 1 (Innovation in Small Molecules, Hybrid LBA/LCMS & Regulated Bioanalysis), Part 3 (Vaccine, Gene/Cell Therapy, NAb Harmonization and Immunogenicity) are published in volume 13 of Bioanalysis, issues 4, and 6 (2021), respectively." @default.
• W3121304865 created "2021-02-01" @default.
• W3121304865 creator A5001077038 @default.
• W3121304865 creator A5001242096 @default.
• W3121304865 creator A5001456717 @default.
• W3121304865 creator A5003560390 @default.
• W3121304865 creator A5007272712 @default.
• W3121304865 creator A5008247815 @default.
• W3121304865 creator A5010897146 @default.
• W3121304865 creator A5011133643 @default.
• W3121304865 creator A5013286857 @default.
• W3121304865 creator A5016055543 @default.
• W3121304865 creator A5016436132 @default.
• W3121304865 creator A5016671715 @default.
• W3121304865 creator A5016772237 @default.
• W3121304865 creator A5017813475 @default.
• W3121304865 creator A5018270022 @default.
• W3121304865 creator A5018465451 @default.
• W3121304865 creator A5019668595 @default.
• W3121304865 creator A5019887269 @default.
• W3121304865 creator A5020079496 @default.
• W3121304865 creator A5020369833 @default.
• W3121304865 creator A5022695070 @default.
• W3121304865 creator A5023090759 @default.
• W3121304865 creator A5024335537 @default.
• W3121304865 creator A5027406352 @default.
• W3121304865 creator A5028059594 @default.
• W3121304865 creator A5030577283 @default.
• W3121304865 creator A5031155500 @default.
• W3121304865 creator A5032257419 @default.
• W3121304865 creator A5032315045 @default.
• W3121304865 creator A5033128251 @default.
• W3121304865 creator A5033709745 @default.
• W3121304865 creator A5033978976 @default.
• W3121304865 creator A5035667102 @default.
• W3121304865 creator A5037795995 @default.
• W3121304865 creator A5039685591 @default.
• W3121304865 creator A5040748828 @default.
• W3121304865 creator A5041974544 @default.
• W3121304865 creator A5043673256 @default.
• W3121304865 creator A5043981884 @default.
• W3121304865 creator A5044306037 @default.
• W3121304865 creator A5045311261 @default.
• W3121304865 creator A5046111959 @default.
• W3121304865 creator A5047040215 @default.
• W3121304865 creator A5051111034 @default.
• W3121304865 creator A5051239108 @default.
• W3121304865 creator A5052238885 @default.
• W3121304865 creator A5052242846 @default.
• W3121304865 creator A5052546923 @default.
• W3121304865 creator A5054978978 @default.
• W3121304865 creator A5055475372 @default.
• W3121304865 creator A5056768459 @default.
• W3121304865 creator A5057908094 @default.
• W3121304865 creator A5058695347 @default.
• W3121304865 creator A5059312550 @default.
• W3121304865 creator A5060056480 @default.
• W3121304865 creator A5062121176 @default.
• W3121304865 creator A5062601988 @default.
• W3121304865 creator A5065263465 @default.
• W3121304865 creator A5066089674 @default.
• W3121304865 creator A5067538223 @default.
• W3121304865 creator A5067846441 @default.
• W3121304865 creator A5067888779 @default.
• W3121304865 creator A5069086023 @default.
• W3121304865 creator A5071972745 @default.
• W3121304865 creator A5074316818 @default.
• W3121304865 creator A5075591900 @default.
• W3121304865 creator A5075752641 @default.
• W3121304865 creator A5079409846 @default.
• W3121304865 creator A5079535759 @default.
• W3121304865 creator A5079593795 @default.
• W3121304865 creator A5080686473 @default.
• W3121304865 creator A5081487988 @default.
• W3121304865 creator A5086611994 @default.
• W3121304865 creator A5086664284 @default.
• W3121304865 creator A5086737974 @default.
• W3121304865 creator A5087687578 @default.
• W3121304865 creator A5088113725 @default.
• W3121304865 creator A5088297113 @default.
• W3121304865 creator A5088820799 @default.
• W3121304865 creator A5089154198 @default.
• W3121304865 creator A5089911601 @default.
• W3121304865 date "2021-03-01" @default.
• W3121304865 modified "2023-10-17" @default.
• W3121304865 title "2020 White Paper on Recent Issues in Bioanalysis: BAV Guidance, CLSI H62, Biotherapeutics Stability, Parallelism Testing, CyTOF and Regulatory Feedback (<u>Part 2A</u> – Recommendations on Biotherapeutics Stability, PK LBA Regulated Bioanalysis, Biomarkers Assays, Cytometry Validation & Innovation <u>Part 2B</u> – Regulatory Agencies’ Inputs on Bioanalysis, Biomarkers, Immunogenicity, Gene & Cell Therapy and Vaccine)" @default.
• W3121304865 cites W1544689380 @default.
• W3121304865 cites W1845477376 @default.
• W3121304865 cites W1963484387 @default.
• W3121304865 cites W1965764567 @default.
• W3121304865 cites W1967295501 @default.
• W3121304865 cites W1981730803 @default.
• W3121304865 cites W1985324181 @default.
• W3121304865 cites W1985903089 @default.
• W3121304865 cites W1990597414 @default.
• W3121304865 cites W1991671417 @default.
• W3121304865 cites W1995836103 @default.
• W3121304865 cites W2001700978 @default.

• next